CLINICAL_TRIALS ClinicalTrials.gov record update

A Clinical Study of Xingbaiji Formula in Combination with Chemotherapy and Sintilimab As First-Line Treatment for Metastatic Multi-Target Mutation-Negative Non-Small Cell Lung Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06848426
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:26:48.408057+00:00
Published At: 2025-02-27T00:00:00+00:00
Record Updated At: 2025-02-27
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Non-Small Cell Lung Cancer", "Non-small Cell Lung Cancer Recurrent", "Non-small Cell Lung Cancer Stage IIIB", "Non-small Cell Lung Cancer Stage IV", "Non-small Cell Lung Cancer Metastatic"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2025-02-27"
protocolSection.identificationModule.nctId: "NCT06848426"
protocolSection.identificationModule.officialTitle: "A Clinical Study of Xingbaiji Formula in Combination with Chemotherapy and Sintilimab As First-Line Treatment for Metastatic Multi-Target Mutation-Negative Non-Small Cell Lung Cancer"
protocolSection.statusModule.overallStatus: "NOT_YET_RECRUITING"
protocolSection.designModule.phases: ["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.